These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21257007)

  • 1. Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS).
    Hosseinpanah F; Barzin M; Sheikholeslami F; Azizi F
    Am J Cardiol; 2011 Feb; 107(3):412-6. PubMed ID: 21257007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.
    Arnlöv J; Ingelsson E; Sundström J; Lind L
    Circulation; 2010 Jan; 121(2):230-6. PubMed ID: 20038741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly Iranians: Tehran lipid and glucose study.
    Mirbolouk M; Asgari S; Sheikholeslami F; Mirbolouk F; Azizi F; Hadaegh F
    Geriatr Gerontol Int; 2015 Apr; 15(4):449-56. PubMed ID: 24750352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20,000 Dutch men and women aged 20-65 years.
    van Dis I; Kromhout D; Geleijnse JM; Boer JM; Verschuren WM
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):729-34. PubMed ID: 19809330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
    Song SH; Hardisty CA
    QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome.
    Onat A; Hergenç G; Keleş I; Doğan Y; Türkmen S; Sansoy V
    Metabolism; 2005 Jun; 54(6):800-8. PubMed ID: 15931618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals.
    Ingelsson E; Sullivan LM; Fox CS; Murabito JM; Benjamin EJ; Polak JF; Meigs JB; Keyes MJ; O'Donnell CJ; Wang TJ; D'Agostino RB; Wolf PA; Vasan RS
    Circulation; 2007 Jul; 116(4):375-84. PubMed ID: 17620505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects.
    Vidal J; Morínigo R; Codoceo VH; Casamitjana R; Pellitero S; Gomis R
    Int J Obes (Lond); 2005 Jun; 29(6):668-74. PubMed ID: 15753955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMI vs. waist circumference for identifying vascular risk.
    Freiberg MS; Pencina MJ; D'Agostino RB; Lanier K; Wilson PW; Vasan RS
    Obesity (Silver Spring); 2008 Feb; 16(2):463-9. PubMed ID: 18239660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of midlife obesity and cardiovascular risk with old age frailty: a 26-year follow-up of initially healthy men.
    Strandberg TE; Sirola J; Pitkälä KH; Tilvis RS; Strandberg AY; Stenholm S
    Int J Obes (Lond); 2012 Sep; 36(9):1153-7. PubMed ID: 22614054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study.
    Kelishadi R; Cook SR; Motlagh ME; Gouya MM; Ardalan G; Motaghian M; Majdzadeh R; Ramezani MA
    J Am Diet Assoc; 2008 Jan; 108(1):82-90. PubMed ID: 18155992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk?
    Gao W;
    Int J Obes (Lond); 2008 May; 32(5):757-62. PubMed ID: 18209738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes.
    Church TS; LaMonte MJ; Barlow CE; Blair SN
    Arch Intern Med; 2005 Oct; 165(18):2114-20. PubMed ID: 16217001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measures of overweight and obesity and risk of cardiovascular disease: a population-based study.
    Sehested TS; Hansen TW; Olsen MH; Abildstrøm SZ; Rasmussen S; Ibsen H; Torp-Pedersen C; Madsbad S; Jeppesen J
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):486-90. PubMed ID: 20134327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abdominal obesity phenotypes and risk of cardiovascular disease in a decade of follow-up: the Tehran Lipid and Glucose Study.
    Keihani S; Hosseinpanah F; Barzin M; Serahati S; Doustmohamadian S; Azizi F
    Atherosclerosis; 2015 Feb; 238(2):256-63. PubMed ID: 25540856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obesity--a risk factor].
    Hlúbik P; Opltová L; Chaloupka J
    Sb Lek; 2002; 103(4):499-509. PubMed ID: 12688165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
    Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
    Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.
    Meigs JB; Wilson PW; Fox CS; Vasan RS; Nathan DM; Sullivan LM; D'Agostino RB
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2906-12. PubMed ID: 16735483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.